Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Camp4 Therapeutics (CAMP) Current Leases (2023 - 2025)

Camp4 Therapeutics' Current Leases history spans 3 years, with the latest figure at $286000.0 for Q4 2025.

  • For Q4 2025, Current Leases fell 90.45% year-over-year to $286000.0; the TTM value through Dec 2025 reached $286000.0, down 90.45%, while the annual FY2025 figure was $286000.0, 90.45% down from the prior year.
  • Current Leases for Q4 2025 was $286000.0 at Camp4 Therapeutics, up from $27000.0 in the prior quarter.
  • Across five years, Current Leases topped out at $3.1 million in Q2 2025 and bottomed at $27000.0 in Q3 2025.
  • The 3-year median for Current Leases is $286000.0 (2025), against an average of $1.0 million.
  • The largest annual shift saw Current Leases soared 745.76% in 2024 before it tumbled 90.45% in 2025.
  • A 3-year view of Current Leases shows it stood at $354000.0 in 2023, then skyrocketed by 745.76% to $3.0 million in 2024, then tumbled by 90.45% to $286000.0 in 2025.
  • Per Business Quant, the three most recent readings for CAMP's Current Leases are $286000.0 (Q4 2025), $27000.0 (Q3 2025), and $3.1 million (Q2 2025).